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bstract
elomerase has long been known to be a marker for cancer. We have developed a new method of detecting it: the electrochemical telomerase
ssay (ECTA). We have previously confirmed that the assay is easier to do and more precise than the conventional telomeric repeat amplification
rotocol, which is currently the most widely used. Here we describe a pilot study made to establish a screening system for oral cancer using
CTA. We evaluated three types of clinical samples obtained from 44 patients with oral cancer and 26 healthy volunteers: exfoliated cells
rom the whole oral cavity, exfoliated cells from local lesions, and tissue from the lesion itself. The current increase ratio (i) obtained by
CTA was significantly higher in the oral cancer group for each type of sampling used. The threshold value for i was 19% when calculated
y analysis of receiver-operating characteristic curves. Sensitivity and specificity values were 86% and 85% for cells from the oral cavity,
2% and 85% in cells from local lesions, and 95% and 92% in cells from the tumour itself, respectively. There were also no significant
ifferences in sensitivity and specificity associated with age, size of tumour, site of lesion, or degree of malignancy. ECTA therefore seems to
e a promising assay for screening for oral cancer.
2016 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
eywords: Telomerase; Electrochemical assay; Oral cancer screening
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cntroduction
ral functions such as chewing, swallowing, and speech have
mportant roles in daily life, and many patients who have
dvanced oral cancers resected are left with various dysfunc-
1,2Please cite this article in press as: Hayakawa M, et al. Electrochemical te
Surg (2015), http://dx.doi.org/10.1016/j.bjoms.2016.01.003
ions and aesthetic problems. Methods that enable earlier
etection of oral cancer may therefore facilitate better out-
omes for them by reducing the amount of resection required.
∗ Corresponding author. Tel.: +81 93 582 1131x1921;
ax: +81 93 582 1286.
E-mail address: tominaga@kyu-dent.ac.jp (K. Tominaga).
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266-4356/© 2016 The British Association of Oral and Maxillofacial Surgeons. Pu
 2016. This manuscript version is made available under the CC-BY-NCTelomerase is an enzyme that elongates the vertebrate
elomere sequence TTAGGG and is associated with cellu-
ar immortalisation. Telomerase activity is present in various
uman cancers, but it is undetectable in most normal somatic
ells.3,4 Its presence is therefore regarded as a marker for
ancer.
The telomeric repeat amplification protocol (TRAP) assay
s a method of measuring telomerase activity based on a
olymerase chain reaction (PCR), but is time-consuming. We
ave developed a new method of electrochemical telomeraselomerase assay for screening for oral cancer. Br J Oral Maxillofac
ssay (ECTA) to measure telomerase activity that does not
equire PCR or subsequent gel electrophoresis.5–7 For ECTA
sample solution is placed on an electrode with immobilised
blished by Elsevier Ltd. All rights reserved.
-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ 
ARTICLE IN PRESSYBJOM-4744; No. of Pages 5
2 M. Hayakawa et al. / British Journal of Oral and Maxillofacial Surgery xxx (2015) xxx–xxx
F 4-(3-Fe
t
t
s
s
c
a
t
w
r
c
t
r
h
i
T
s
c
t
s
o
o
M
T
o
s
M
c
w
h
P
e
t
w
m
f
o
s
T
(
e
d
h
(
f
e
s
b
t
t
p
c
with an interdental brush, as is routine for cytodiagnosis. We
consider this collection method suitable for use as part of
a medical examination for oral cancer by a dentist or other
Table 1
Details of patients with oral cancer.
Variable Number
Sex:
Male 24
Female 20
Site:
Tongue 24
Gingiva 16
Floor of mouth 3
Buccal mucosa 1
Stage of tumour:
T1 15
T2 24
T3 1
T4 4
Histopathological differentiation:ig. 1. Diagram of the electrochemical telomerase assay. FND= N,N’-bis[[
etracarboxylic acid diimide.
elomerase substrate primer, and the current value is mea-
ured. If it detects telomerase activity, the telomerase
ubstrate is elongated and the current value increases. The
urrent increase ratio (i) reflects the amount of telomerase
ctivity (Fig. 1).
We previously compared the ability of ECTA and TRAP
o detect telomerase activity in four cancer cell lines that
ere derived from oral cancers.7 ECTA could detect telome-
ase activity in as little as 8 ng protein (equivalent to about 10
ancer cells), while TRAP required at least 20 times more pro-
ein. However, in ECTA the i value reached a plateau with
elatively few cancer cells present in the sample, so ECTA is a
ighly sensitive assay for telomerase activity, which is qual-
tative but not quantitative. We then compared ECTA with
RAP in a clinical trial using both tissue and exfoliated cells
cratched from the oral mucosa of patients with oral can-
er, and it was vastly superior to TRAP in the detection of
elomerase activity from both tissue and cells.
In the present study we aimed to establish an ECTA-based
creening system for oral cancer by evaluating the reliability
f ECTA in three types of clinical samples from patients with
ral cancer.
aterial and methods
he study was cross-sectional and done in the Department
f Oral and Maxillofacial Surgery, Kyushu Dental Univer-
ity Hospital, Fukuoka, Japan between September 2010 and
arch 2013. Ethical approval was provided by the ethics
ommittee of Kyushu Dental University (10-19). Samples
ere obtained from 44 patients with oral cancer and 26
ealthy volunteers, all of whom gave informed consent.
atients who had previously been treated for oral cancer by
xcision, irradiation, or chemotherapy were excluded from
he study. All patients were diagnosed histopathologicallyPlease cite this article in press as: Hayakawa M, et al. Electrochemical te
Surg (2015), http://dx.doi.org/10.1016/j.bjoms.2016.01.003
ith squamous cell carcinoma (SCC).
The oral cancer group comprised 24 men and 20 women,
ean age 69 (range 34–87) years. Specimens were obtained
rom SCC of the tongue (n=24), the gingiva (n=16), the floorrrocenepropionamidopropyl)-piperazin-1-yl]propyl]-naphthalene- 1,4,5,8-
f mouth (n=3), and the buccal mucosa (n=1). Tumours were
ized according to the UICC criteria: T1 (< 2 cm, n=15),
2 (<4 cm but ≥2 cm, n=24), T3 (≥4 cm, n=1), and T4
includes invasion of nearby tissue, n=4). Histopathological
xamination identified 27 well-differentiated, 16 moderately
ifferentiated, and 1 poorly differentiated SCC (Table 1). The
ealthy volunteers were 17 men and 9 women, mean age 47
range 24–84) years.
Samples were collected in three ways. Exfoliated cells
rom the whole oral cavity were collected by scratching the
ntire oral cavity with a sponge-type brush (2 × 2 cm). Five
cratches were made on the left and right buccal mucosa, the
uccal and lingual gingiva of the upper and lower jaws, and
he lingual margin of the tongue. We consider this collec-
ion method suitable for use as a self-screening system for
atients concerned about oral cancer. Samples of exfoliated
ells from local lesions were collected by scratching a lesionlomerase assay for screening for oral cancer. Br J Oral Maxillofac
Good 27
Moderate 16
Poor 1
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Table 2
Sensitivity, specificity, false positive, and false negative values for exfoliated
cells from the whole oral cavity, from local lesions, and from the lesion itself.
Variable Exfoliated
cells from the
oral cavity
Local
exfoliated
cells
Tissue from
the lesion
No of patients with oral
cancer
44 44 42
No of healthy volunteers 26 26 13
Sensitivity (%) 86 82 95
Specificity (%) 85 85 92
False positive rate (%) 15 15 8
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(Table 2).alse negative rate (%) 14 18 5
edical practitioner. Samples from healthy volunteers were
ollected from the tongue or buccal mucosa. The third method
as tissue taken from the lesion. For the oral cancer group,
issue samples of about 1.5 ×  1.5 ×  1.5 mm were obtained by
esection from the centre of the lesion. For the healthy volun-
eers, similar-sized samples were collected from the tongue
r buccal mucosa.
reparation  and  measurement  of  samples
ll samples were homogenised in lysis buffer 500 l
Tris-hydrochloric acid (pH 7.5) 10 mmol, magnesium chlo-
ide 1 mmol, ECTA 1 mmol, benzamidine 0.1 mmol,
-mercaptoethanol 5 mmol, 0.5% CHAPS, 10% glycerol)
nd stored at −80 ◦C. Samples from the oral cavity were
esuspended in saline 20 ml and centrifuged at 20400 g for
 minutes at 4 ◦C before homogenisation. Stored samples
ere thawed and spun in a microcentrifuge at 20400 g
or 30 minutes at 4 ◦C before each assay, and the super-
atant that contained the telomerase was collected. Protein
oncentrations were measured using a Proteostain Pro-
ein Quantification Kit-Wide Range (Dojindo, Kumamoto,
apan).8 Protein concentrations were adjusted to 400 ng/l.
henever possible, nuclease-free buffers and reagents were
sed to minimize RNase contamination. After preparation,
amples were kept in the same type of tube and assigned a
umber so that investigators were unaware of the patients’
ata.
Electrochemical measurements were made using a
ortable apparatus with a three-electrode configuration.
 platinum electrode served as the counter electrode, a
ilver/silver chloride electrode as the reference electrode,
nd a telomerase substrate primer-immobilised electrode
s the working electrode.5–7 Osteryoung square wave
oltammetry (SWV) values were calculated in 20 m
,N’-bis[[4-(3-Ferrocenepropionamidopropyl)-piperazin-
-yl]propyl]-naphthalene- 1,4,5,8-tetracarboxylic acid
iimide4, acetic acid-potassium acetate 0.10 M and potas-
ium chloride 0.10 M before and after the telomerase reactionPlease cite this article in press as: Hayakawa M, et al. Electrochemical te
Surg  (2015), http://dx.doi.org/10.1016/j.bjoms.2016.01.003
sing a procedure previously described.5–7 For each reaction,
eaction solution 20 l (lysate 40 ng/l, Tris-hydrochloric
cid (50 mmol, pH 8.0), magnesium chloride1.0 mmol,
i
HFig. 2. Rate of increased ratio after electrochemical telomerase assay.
otassium chloride 50 mmol, 2-mercaptoethanol 0.10
mol, spermidine 0.10 mmol, and deoxynucleotide mixture
0 mol) was placed on the electrode at 37 ◦C for 30 minutes.
ll data were standardised with i, which was defined as
i/i0 −  1) ×  100%, where i0 and i refer to the current before
nd after the reaction, respectively (Fig. 1).
nalyses  of  data
ifferences in the median values of i were assessed using
he Mann–Whitney U  test. Probabilities of less than 0.05
ere accepted as significant. Analysis of receiver-operating
haracteristic (ROC) curves was used to establish threshold
alues, after which the sensitivity, specificity, false positive
ate, and false negative rate were calculated. All statistical
nalyses were made with the aid of SPSS software (version
1, SPSS, Chicago, IL, USA).
esults
ithin each of the three types of sample the oral cancer group
ad a significantly higher i than the healthy volunteers
p < 0.001; Fig. 2). Interestingly, there was no difference in
he outcome of the i value between samples obtained from
he oral cavity or the tumour itself, which might include many
ewer, or many more, cancer cells, respectively.
The area under the curve for ROC curve analysis was 0.938
Fig. 3). This analysis assigned 19%i as a threshold value.
hat is, a value less than 19%i was regarded as a negative
esult, while greater than 19%i was regarded as positive.
e used a 19%i threshold value to yield sensitivity and
pecificity values, which confirmed that ECTA can discrim-
nate positive and negative samples even in exfoliated cellslomerase assay for screening for oral cancer. Br  J  Oral  Maxillofac
Detection of small tumours such as those classed as T1
s usually more difficult than detection of large tumours.
owever, the sensitivity and specificity values for ECTA
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Table 3
Sensitivity, specificity, false positive, and false negative rates in samples of cancer from exfoliated cells from the whole oral cavity, from local lesions, and from
the lesion itself.
Source of cells No of patients with oral cancer Sensitivity (%) Specificity (%) False positive (%) False negative (%)
Oral cavity*
T stage:
1 15 93 85 15 7
2-4 29 83 85 15 17
Site: 24 88 85 15 13
Tongue 24 88 85 15 13
Other 20 85 85 15 15
Differentiation:
Poor/moderate 17 82 85 15 18
Good 27 89 85 15 11
Local lesions*
T stage:
1 15 80 85 15 20
2-4 29 83 85 15 17
Site:
Tongue 24 83 85 15 17
Other 20 85 85 15 15
Differentiation:
Poor/moderate 17 88 85 15 12
Good 27 78 85 15 22
The lesion itself**
T stage:
1 14 100 92 8 0
2-4 28 93 92 8 7
Site:
Tongue 22 95 92 8 5
Other 20 95 92 8 5
Differentiation:
Poor/moderate 16 94 92 8 6
* voluntee
i
d
s
s
o
i
D
I
e
aGood 26 96 
=compared with 26 healthy volunteers and **=compared with 13 healthy 
n detecting T1 tumours did not differ from those for the
etection of larger tumours (Table 3). The sensitivity and
pecificity of the detection of telomerase activity was the
ame regardless of sampling site, even for samples from the
ral cavity. ECTA results did not seem to reflect the histolog-Please cite this article in press as: Hayakawa M, et al. Electrochemical te
Surg  (2015), http://dx.doi.org/10.1016/j.bjoms.2016.01.003
cal character of the tumours.
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Fig. 3. Receiver-operating characteristic curve of all samples.
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iscussion
t is usually possible to see and examine oral cancers. How-
ver, various mucosal diseases can impair its early detection,
s neoplastic lesions are not always obvious to general den-
ists who are not specially trained in oral surgery or oral
eoplasia. Several methods by which general dentists can
etect oral cancer have therefore been reported, including
ital staining with iodine9 or toluidine blue,10 and imaging
ased on autofluorescence.11 However, interpretation of the
esults is subjective and often not clear, which renders them
argely unreliable.
Detection of telomerase activity has been mentioned as a
seful diagnostic strategy for cancer, as most cancers possess
t. The conventional primer extension-based assay requires
 large sample and has low sensitivity. These disadvantages
ere overcome by the TRAP assay established by Kim et
l,12 but that assay requires PCR and gel electrophoresis,
nd has the weakness that it may be impaired if inhibitors
f PCR are present in samples. Saliva usually contains
Nase, so contamination of a TRAP assay by RNase is
navoidable when using samples of oral origin. Assessmentlomerase assay for screening for oral cancer. Br  J  Oral  Maxillofac
f telomerase activity using TRAP is by observation of the
CR amplification products after gel electrophoresis, so
uch judgements are also subjective and often not clear.13
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ecause ECTA does not involve PCR, it is less influenced
y RNase in saliva, and it can measure telomerase activity
ore quickly and precisely. Analysis of the ROC curve also
ndicates that ECTA has optimal discriminative ability. It
s simple, and once a threshold value is established, it can
e used as an ordinary objective examination that does not
equire a specially-trained examiner.
A similar increase in current occurred regardless of
hether few (in samples from the oral cavity) or many (in
amples from the tumour itself) cancer cells were present.
his finding is important, as the oral cavity method of samp-
ing enables detection of a small cancerous lesion almost
nywhere within the oral cavity. It can also identify a can-
er regardless of the site of onset, which could facilitate
elf-examination or mass examination. While ECTA did not
eflect the stage of malignancy of the cancer, this is not critical
or a screen, as grade can be evaluated by biopsy of lesions
n patients who return a doubtful result.
One weakness of this study is the lack of comparison
etween ECTA and a conventional diagnostic method such
s cytology using the same sample. More, larger studies
re needed to validate the superiority of ECTA over well-
stablished methods. However, these methods need specially-
rained oral cytologists to interpret them or they are also sub-
ective examinations. ECTA may be used as screening tool,
owever, because it is a promising objective examination that
ould potentially be used with samples of other body fluids
uch as urine, bronchoalveolar lavage, and pleural effusion.
In conclusion, we have developed a screening system for
ral cancer based on measurement of telomerase activity
sing ECTA. We used exfoliated cells from the whole oral
avity, from a local lesion, and from samples of tissue from
he tumour itself to evaluate the ability of ECTA to discrimi-
ate patients with oral cancer from healthy volunteers. ECTA
ould identify telomerase activity in oral cancers regardless
f type of sample, size of tumour, or site of lesion, and so
ay well be a promising tool for screening for oral cancer.Please cite this article in press as: Hayakawa M, et al. Electrochemical te
Surg  (2015), http://dx.doi.org/10.1016/j.bjoms.2016.01.003
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